» Articles » PMID: 19491243

Changes in Visceral Adipose Tissue Mitochondrial Content with Type 2 Diabetes and Daily Voluntary Wheel Running in OLETF Rats

Overview
Journal J Physiol
Specialty Physiology
Date 2009 Jun 4
PMID 19491243
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Using the hyperphagic, obese, Otsuka Long-Evans Tokushima Fatty (OLETF) rat, we sought to determine if progression to type 2 diabetes alters visceral white adipose tissue (WAT) mitochondrial content and if these changes are modified through prevention of type 2 diabetes with daily exercise. At 4 weeks of age, OLETF rats began voluntary wheel running (OLETF-EX) while additional OLETF rats (OLETF-SED) and Long-Evans Tokushima Otsuka (LETO-SED) rats served as obese and lean sedentary controls, respectively, for 13, 20 and 40 weeks of age (n = 6-8 for each group at each age). OLETF-SED animals displayed insulin resistance at 13 and 20 weeks and type 2 diabetes by 40 weeks. OLETF-SED animals gained significantly (P < 0.001) more weight and omental fat mass compared with OLETF-EX and LETO-SED. Markers of WAT mitochondrial protein content (cytochrome c, COXIV-subunit I, and citrate synthase activity) significantly increased (P < 0.05) from 13 to 40 weeks in the LETO-SED, but were significantly attenuated in the OLETF-SED rats. Daily exercise normalized WAT cytochrome c and COXIV-subunit I protein content in the OLETF-EX to the healthy LETO-SED animals. In conclusion, increases in omental WAT mitochondrial content between 20 and 40 weeks of age in LETO control animals are attenuated in the hyperphagic, obese OLETF rat. These alterations occurred in conjunction with the progression from insulin resistance to type 2 diabetes and were prevented with daily exercise. Reduced ability to increase WAT mitochondrial content does not appear to be a primary cause of insulin resistance, but may play a key role in the worsening of the disease condition.

Citing Articles

Voluntary exercise fails to prevent metabolic dysfunction-associated steatotic liver disease progression in male rats fed a high-fat high-cholesterol diet.

Besqueut-Rougerie C, Chavanelle V, Michaux A, Otero Y, Sirvent P, King J Physiol Rep. 2024; 12(8):e15993.

PMID: 38627215 PMC: 11021195. DOI: 10.14814/phy2.15993.


Exercise and inactivity as modifiers of β cell function and type 2 diabetes risk.

Hall L, Thyfault J, Johnson J J Appl Physiol (1985). 2023; 134(4):823-839.

PMID: 36759159 PMC: 10042613. DOI: 10.1152/japplphysiol.00472.2022.


mtDNA haplogroup A enhances the effect of obesity on the risk of knee OA in a Mexican population.

Ramos-Louro P, Arellano Perez Vertti R, Reyes A, Martinez-Nava G, Espinosa R, Pineda C Sci Rep. 2022; 12(1):5173.

PMID: 35338224 PMC: 8956628. DOI: 10.1038/s41598-022-09265-y.


Healthy versus Unhealthy Adipose Tissue Expansion: the Role of Exercise.

Meister B, Hong S, Shin J, Rath M, Sayoc J, Park J J Obes Metab Syndr. 2022; 31(1):37-50.

PMID: 35283364 PMC: 8987461. DOI: 10.7570/jomes21096.


Postnatal exercise protects offspring from high-fat diet-induced reductions in subcutaneous adipocyte beiging in C57Bl6/J mice.

Claycombe-Larson K, Bundy A, Lance E, Darland D, Casperson S, Roemmich J J Nutr Biochem. 2021; 99:108853.

PMID: 34517093 PMC: 9040048. DOI: 10.1016/j.jnutbio.2021.108853.


References
1.
Rector R, Thyfault J, Morris R, Laye M, Borengasser S, Booth F . Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. Am J Physiol Gastrointest Liver Physiol. 2008; 294(3):G619-26. DOI: 10.1152/ajpgi.00428.2007. View

2.
He J, Watkins S, Kelley D . Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes. 2001; 50(4):817-23. DOI: 10.2337/diabetes.50.4.817. View

3.
Wilson-Fritch L, Burkart A, Bell G, Mendelson K, Leszyk J, Nicoloro S . Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol Cell Biol. 2003; 23(3):1085-94. PMC: 140688. DOI: 10.1128/MCB.23.3.1085-1094.2003. View

4.
Wilson-Fritch L, Nicoloro S, Chouinard M, Lazar M, Chui P, Leszyk J . Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest. 2004; 114(9):1281-9. PMC: 524228. DOI: 10.1172/JCI21752. View

5.
Boden G, Homko C, Mozzoli M, Showe L, Nichols C, Cheung P . Thiazolidinediones upregulate fatty acid uptake and oxidation in adipose tissue of diabetic patients. Diabetes. 2005; 54(3):880-5. DOI: 10.2337/diabetes.54.3.880. View